Skip to main content
Elsevier
View Cart
My account

Books in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

BooksJournals

    • Pharmacy Law and Practice

      • 4th Edition
      • July 10, 2006
      • Jon Merrills + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 4 5 2 2 0 1 6
      • eBook
        9 7 8 0 0 8 0 4 7 9 9 6 5
      Suitable for both students and practicing pharmacists, the latest edition of this classic textbook provides comprehensive coverage of an essential component of the U.K. pharmacy curriculum: pharmacy law and ethics. Completely rewritten since the last edition to reflect the rapid pace at which this field moves, it offers a clear, readable and non-technical guide on balancing the needs of patients with the letter of the law. It explains what happens and why in a reader-friendly format, taking a problem solving approach, and even provides an introduction to pharmacy issues for solicitors and legal personnel. Any pharmacist, student, or regulatory authority will find it appropriate for either a serious study or for answering questions which occur in practice.

    • Chondroitin Sulfate

      • 1st Edition
      • Volume 53
      • June 28, 2006
      • English
      • eBook
        9 7 8 0 0 8 0 4 7 1 9 5 2
      CS is an unbranched, polydisperse, complex glycosaminoglycan extracted and purified from various tissues. This polyanion is interacting with both plasma and cells, it is able to modulate many biochemical and physiologic processes. Due to the presence of sulfate groups in different amounts and located in various positions, CS represents a very heterogeneous family of polysaccharides. therefore, the preparative approach and the analytical techniques are of paramount importance to produce CS with specific structure and properties and of pharmaceutical grade.

    • Principles of Clinical Pharmacology

      • 2nd Edition
      • September 20, 2006
      • Arthur J. Atkinson Jr. + 4 more
      • English
      • eBook
        9 7 8 0 0 8 0 4 6 6 4 2 2
      This revised second edition covers the pharmacologic principles underlying the individualization of patient therapy and contemporary drug development, focusing on the fundamentals that underlie the clinical use and contemporary development of pharmaceuticals. Authors drawn from academia, the pharmaceutical industry and government agencies cover the spectrum of material, including pharmacokinetic practice questions, covered by the basic science section of the certifying examination offered by the American Board of Clinical Pharmacology. This unique reference is recommended by the Board as a study text and includes modules on drug discovery and development to assist students as well as practicing pharmacologists.

    • Pharmaceutical Manufacturing Encyclopedia

      • 3rd Edition
      • December 1, 2006
      • William Andrew William Andrew Publishing
      • English
      • eBook
        9 7 8 0 8 1 5 5 1 8 5 6 3
      • eBook
        9 7 8 0 0 8 0 9 4 7 2 6 6
      This industry standard encyclopedia on pharmaceutical manufacturing processes has been completely updated to include FDA drugs approved up to the summer of 2004. The encyclopedia gives details for the manufacture of 2226 pharmaceuticals that are being marketed as a trade-named product somewhere in the world. Each entry includes:ò Therapeutic function ò Chemical and common nameò Structural Formulaò Chemical Abstracts Registry no.ò Trade name, manufacturer, country, and year introducedò Raw Materialsò Manufacturing ProcessIn addition, references are also cited under each drug's entry to major pharmaceutical works where additional information can be obtained on synthesis and the pharmacology of the individual products.

    • Side Effects of Drugs Annual

      • 1st Edition
      • Volume 28
      • November 29, 2005
      • Jeffrey K. Aronson
      • English
      • Paperback
        9 7 8 0 4 4 4 5 4 2 8 6 1
      • Paperback
        9 7 8 0 4 4 4 5 1 5 7 1 1
      • eBook
        9 7 8 0 0 8 0 4 5 9 5 0 9
      Volume 28 in the series of Side Effects of Drugs Annuals (http://www.elsevier... continues to serve its primary goal: to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has reviewed new data and trends by selecting from the year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is unproven or misleading. The use of the book is enhanced by separate indexes, allowing the reader to access the text via drug name, adverse effect, or drug interaction. The current annual includes an essay by the editor, Dr Jeffrey Aronson, entitled 'Classifying Drug Adverse Reactions in the 21st Century.' In it he describes how the modern approach to classifying adverse drug reactions takes into account the dose that causes the reaction, the time-course of the reaction, and the susceptibility factors that increase the individual patient's risk, and shows how this analysis can facilitate regulatory decision making.

    • Handbook of Neuroemergency Clinical Trials

      • 1st Edition
      • December 15, 2005
      • Wayne M. Alves + 1 more
      • English
      • Hardback
        9 7 8 0 1 2 6 4 8 0 8 2 5
      • eBook
        9 7 8 0 0 8 0 4 5 4 3 5 1
      During the 1990’s, scientific advances in understanding the mechanisms and pathophysiology of acute central nervous system injury were offset by a history of disappointing results from Phase III clinical trials of novel neuroprotective drugs. Numerous novel compounds were “tested,” and seemingly fell by the wayside. This book is intended to focus on novel therapies and the unique challenges their intended targets pose for the design and analysis of clinical trials. The authors explore the issues facing research in this area and the strategies that might lead to future success in this critical area of unmet medical need. It represents a compendium of information gained from over 20 years of clinical trial experience in areas of acute neurology and neurosurgery. From the knowledge of clinical assessment using standardized tools, to the intricate design of difficult hyper-acute neuroemergencies trials, the reader will benefit from the authors’ perspectives.

    • Annual Reports in Medicinal Chemistry

      • 1st Edition
      • Volume 40
      • December 19, 2005
      • Annette M. Doherty
      • English
      • Paperback
        9 7 8 0 1 2 0 4 0 5 4 0 4
      • eBook
        9 7 8 0 0 8 0 4 5 8 1 7 5
      Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expected to provide the basis for entirely new future therapies. Sections I-IV are disease orientated and generally report on specific medicinal agents. Sections V and VI continue to emphasize important topics in medicinal chemistry, biology, and drug design. Section VII looks at Trends and Perspectives in the pharmaceuticals market.

    • Novel Anticancer Agents

      • 1st Edition
      • December 13, 2005
      • Alex A. Adjei + 1 more
      • English
      • Hardback
        9 7 8 0 1 2 0 8 8 5 6 1 9
      • eBook
        9 7 8 0 0 8 0 5 3 7 7 5 7
      Novel Anticancer Agents offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents. This book covers basic science strategies that are being used in drug discovery and preclinical evaluation focused on novel molecular targets, as well as clinical trial methodology including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new, relatively non-cytotoxic anticancer agents. At present, there is no book that provides such an integration of basic and clinical studies of novel anticancer agents, covering both drug discovery and translational research extensively.

    • Encyclopedia of Heart Diseases

      • 1st Edition
      • December 5, 2005
      • M. Gabriel Khan
      • English
      • Hardback
        9 7 8 0 1 2 4 0 6 0 6 1 6
      • eBook
        9 7 8 0 0 8 0 4 5 4 8 1 8
      The Encyclopedia of Heart Diseases is an accurate and reliable source of in-depth information on the diseases that kill more than 12 million individuals worldwide each year. In fact, cardiovascular diseases are more prevalent than the combined incidence of all forms of cancer, diabetes, asthma and leukemia. In one volume, this Encylopedia thoroughly covers these ailments and also includes in-depth analysis of less common and rare heart conditions to round out the volume's scope. Researchers, clinicians, and students alike will all find this resource an invaluable tool for quick reference before approaching the primary literature.

    • Roles of Vasopressin and Oxytocin in Memory Processing

      • 1st Edition
      • Volume 50
      • August 30, 2004
      • Barbara McEwen
      • English
      • eBook
        9 7 8 0 0 8 0 5 2 4 5 1 1
      The Roles of Vasopressin and Oxytocin in Memory Processing reviews research progress in a subfield of Behavioral Pharmacology concerned with vasopressin’s (VP’s) and oxytocin (OT’s) roles in memory processing (MP). As hormones, VP is well-known for its pressor and antidiuretic action, and OT for its contribution to parturition and nursing. As neurotransmitters, they participate in a wide variety of self- and species-preserving functions expressed at psychological, physiological and behavioral levels. Advances in Pharmacology is available online on ScienceDirect — full-text online of volumes 48 onwards. Elsevier book series on ScienceDirect gives multiple users throughout an institution simultaneous online access to an important compliment to primary research. Digital delivery ensures users reliable, 24-hour access to the latest peer-reviewed content. The Elsevier book series are compiled and written by the most highly regarded authors in their fields and are selected from across the globe using Elsevier’s extensive researcher network. For more information about the Elsevier Book Series on ScienceDirect Program, please visit:http://www.inf...

Related subjects

Biochemical pharmacology

Cardiovascular pharmacology

Clinical pharmacology therapeutics

Clinical trials

Drug adverse reactions and interactions

Endocrine exocrine pharmacology

Ethnopharmacology

Gastrointestinal pharmacology

Immunopharmacology pharmacology

Molecular pharmacology

Neoplastic cancer pharmacology

Pharmacokinetics pharmacodynamics

Pharmacology general

Principles of pharmacology

Psychoneuropharmacology

Pulmonary pharmacology

Renal and electrolyte pharmacology